Press release
Physician Dispensed Cosmeceuticals Market Report Forecasts Strong Growth by 2024
The market for physician dispensed cosmeceuticals has been undergoing a sea change with skincare specialist, dermatologists, and trichologists venturing into the market as entrepreneurs. Consequently, the vendor landscape in the market is becoming highly fragmented due to the mushrooming skin and hair treatment centers and clinics. The market therefore exhibits an abundance of products. It is important for products to conform to consumer expectations to gain a stronghold in this market.View Full Report: http://www.transparencymarketresearch.com/physician-dispensed-cosmeceuticals-market.html
The ground level knowledge about the dynamic consumer preferences, adverse effects of a stressful lifestyle, damages caused to skin, eyes, and hair by UV rays, and the impact of pollution, are the primary factors fuelling the demand for quality physician dispensed cosmeceuticals. As per Transparency Market Research (TMR), these favorable factors will lead the global physician dispensed cosmeceuticals market to report a CAGR of 10.6% between 2016 and 2024. The market is expected to reach US$27.6 bn by the end of 2024, from a valuation of US$11.2 bn in 2015.
Skincare Products Segment leads the Market, but Demand for Injectable Botox to Grow Rapidly
By product type, the skincare products segment held the lion’s share in 2015. The prominence of skincare products can be attributed to the increasing demand for effective cosmeceuticals to treat dermatological conditions. Hence, the increasing consciousness among the aging population about their looks and the changing attitude of the middle-aged and geriatric population in developing countries bode well for the demand for physician dispensed cosmeceuticals.
Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=565
The anti-aging products segment is therefore expected to continue its dominance in the market through the forecast period. However, according to TMR, the demand for injectable Botox is expected to increase at a higher pace in the near future.
North America Emerges as Key Region in Global Physician Dispensed Cosmeceuticals Market
North America, being a mature market, makes a sizeable contribution to physician dispensed cosmeceuticals revenues worldwide. In 2015, the region also emerged dominant in the global market because it is technologically ahead of other geographical segments. As per TMR, the North America physician dispensed cosmeceuticals market stood at US$4.7 bn in 2015. Rising at a CAGR of 9.6%, the market is expected to reach US$10.52 bn by the end of 2024.
However, TMR forecasts that the market in Asia Pacific will grow at the fastest rate during the forecast period. The increasing willingness among the aging and middle-income group population to pay for beauty and skincare products transcends into high demand for quality cosmeceuticals from this region. Furthermore, Asia Pacific boasts a high consumer base for skin whitening, acne treatment, and hyperpigmentation products due to its tropical climate and the higher ratio of teenage population. Bolstered by these factors, the market Asia Pacific is projected to rise at a CAGR of 12.3% between 2016 and 2024.
Request to download and view full ToC - http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=565
Emerging Economies to Exhibit Impressive Opportunities for Increased Sales
Likewise, the demand for physician dispensed cosmeceuticals across other emerging markets such as South Africa, Brazil, Saudi Arabia, and the UAE is expected to rise at a robust pace during the forecast period. On the flip side, high revenue generating cosmeceuticals products such as dermal fillers and Botox have a miniscule consumer base in developing and underdeveloped regions. This is mainly because of their high cost, apprehensions associated with using such products, and lack of sufficient knowledge regarding the use of these products. These factors have an adverse impact on the overall prospects of the market.
Some of the key players operating in the market include Johnson & Johnson, Jan Marini Skin Research, Inc., Allergan plc, Procter & Gamble Co., L'Oreal S.A., Unilever plc, Valeant Pharmaceuticals Inc., and ZO Skin Health Inc. Among these enterprises L'Oreal S.A has emerged as the dominant player in the market.
Global Physician Dispensed Cosmeceuticals Market Report is available @ US$ 5795: http://www.transparencymarketresearch.com/checkout.php?rep_id=565<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Physician Dispensed Cosmeceuticals Market Report Forecasts Strong Growth by 2024 here
News-ID: 698343 • Views: …
More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…

North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…

Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Physician
Physician Scheduling Systems Market 2026
This report focuses on the global Physician Scheduling Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Physician Scheduling Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Spok
ABILITY Network
Qgenda
Intrigma
OpenTempo
Medevision
Mediware Information Systems
MDSYNCNET
Jituzu
Lightning Bolt Solutions
McKesson
Business Management Systems
Market segment by Type, the product can be split into
Software
Services
Market segment by Application, split…
The Physician-Patient Relationship in Telemedicine
Telemedicine should be the modality used when considered to be in the best interest of the patient, for example when it can advance the possibility of treatment otherwise inaccessible, or where contact or physical presence in a clinical setting is not possible due to various constraints brought on by, geography or accessibility, illness or incapacitation, or being part of the medically underserved urban and rural populations.
Is…
Third Physician Group and First Orthopedic Practice Joins White Plains Hospital …
White Plains Hospital recently welcomed Westchester Orthopaedic Associates to its larger family. The practice of Louis McIntyre, M.D.; Michael Panio, M.D.; and Eric Zitzmann, M.D. is the third physician group to join the White Plains Hospital Physician Associates, a recently formed division of the hospital aligning local doctors with Hospital services. This new venture enables physicians and White Plains Hospital to share information, promote growth, better utilize resources…
First Physician Group Joins White Plains Hospital Physician Associates
White Plains, NY – White Plains Hospital recently welcomed White Plains Surgical Specialists, formerly known as Weber, Weber and Yee, to the White Plains Hospital family. Additionally, as of August 1st, surgeon Kaare Weber joined the group. The practice becomes the first member of White Plains Hospital Physician Associates, a newly formed division of the Hospital, developed with the intent of aligning local practicing physicians with the Hospital. This new…
Physician Assistant Programs 101 Guides Career Hopefuls On The Path To Becoming …
The health care industry is a growth sector of the American economy with thousands of jobs expected to be open in the coming years. It was once thought that health care was little more than doctors and nurses, but that has changed dramatically. New professions have grown up within the industry and physician assistant is one of them. It is anticipated that this one job category alone will experience growth…
UCLA Physician Named Care Champion
The National Association For Continence (NAFC) awarded Shlomo Raz, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics & Female Urology (SUFU) annual meeting in St. Petersburg, FL on February 26, 2010. The honor, presented by Eric Rovner, MD, professor of Urology at the Medical University of South Carolina and a member of NAFC’s Board of Directors, is sponsored by Pfizer Global Pharmaceuticals.
Originally…